Publications
15
Citations
221
Est. group size
—
Recurring co-author estimate
Active years
13
Publishing since 2013
This researcher works on designing and testing small molecules and chemical ligands aimed at prostate cancer, particularly compounds that target the prostate-specific membrane antigen (PSMA), a protein often overexpressed in prostate cancer cells. The work combines computational modeling (such as structure-activity relationship studies and molecular docking) with laboratory synthesis and biological testing to develop potential diagnostic and therapeutic agents. Some publications also branch into related areas like nanosensors for detecting metals and, more recently, AI-assisted software development.
Publication output has been uneven over the last decade, with a burst of activity in 2018, a gap in 2021-2022, and a recent uptick in 2025, averaging about 1.2 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Design, synthesis, and biological evaluation of novel thiourea derivatives as small molecule inhibitors for prostate specific membrane antigen
Bioorganic Chemistry · 2025
- Recommendation Framework for Generative AI-Assisted Software Development
Lecture notes in networks and systems · 2025
- Structure activity relationships (SAR) study to design and synthesize new tubulin inhibitors with enhanced anti-tubulin activity: In silico and in vitro analysis
Journal of Molecular Structure · 2020
- Comparison of prostate‐specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer
Cancer Reports · 2019
- Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies
Bioorganic Chemistry · 2019
- Efficient “turn-on” nanosensor by dual emission-quenching mechanism of functionalized Se doped ZnO nanorods for mercury (II) detection
Applied Nanoscience · 2018
- Synthesis of tubuphenylalanine and epi-tubuphenylalanine via regioselective aziridine ring opening with carbon nucleophiles followed by hydroboration-oxidation of 1,1-substituted amino alkenes
Tetrahedron · 2018
- Novel solid-phase strategy for the synthesis of ligand-targeted fluorescent-labelled chelating peptide conjugates as a theranostic tool for cancer
Beilstein Journal of Organic Chemistry · 2018
- First report on 3D-QSAR and molecular dynamics based docking studies of GCPII inhibitors for targeted drug delivery applications
Journal of Molecular Structure · 2018
- Preparation of Ligand‐Targeted Drug Conjugates for Cancer Therapy and Their Evaluation <i>In Vitro</i>
Current Protocols in Chemical Biology · 2018
- Journal of Molecular Structure×2
- Bioorganic Chemistry×2
- Frontiers in Immunology×1
- Chemistry - An Asian Journal×1
- Cancers×1
- Enming Xing
Medicine · The Ohio State University
- Pete E. Pascuzzi
Medicine · Purdue University West Lafayette
- Edmund Folefac
Medicine · The Ohio State University
- Mark Tann
Medicine · Indiana University
- Craig J. Burd
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile